Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
autologous umbilical cord blood (1 trial)
amantadine (symmetrel) (1 trial)
Spinal Cord Injuries (Phase 1)
Stroke (Phase 1)
Wounds and Injuries (Phase 1)
Trials (3 total)
Trial APIs (3 total)